Dormant Company Accounts - MEDIPOINTER LTD

Dormant Company Accounts - MEDIPOINTER LTD

MEDIPOINTER LTD - Company Information

Print Friendly Version

true 2017-01-01 2017-12-31 false 09744346 uk-bus:Director1 2017-01-01 2017-12-31 09744346 uk-bus:Director2 2017-01-01 2017-12-31 09744346 2017-01-01 2017-12-31 09744346 2017-12-31 09744346 uk-bus:EntityHasNeverTraded 2017-01-01 2017-12-31 09744346 uk-bus:FRS102 2017-01-01 2017-12-31 09744346 uk-bus:FullAccounts 2017-01-01 2017-12-31 09744346 uk-bus:AuditExempt-NoAccountantsReport 2017-01-01 2017-12-31 09744346 2016-12-31 09744346 uk-bus:OrdinaryShareClass1 2017-01-01 2017-12-31 09744346 uk-bus:OrdinaryShareClass2 2017-01-01 2017-12-31 09744346 uk-bus:OrdinaryShareClass3 2017-01-01 2017-12-31 09744346 uk-bus:PreferenceShareClass1 2017-01-01 2017-12-31 09744346 uk-bus:PreferenceShareClass2 2017-01-01 2017-12-31 09744346 uk-bus:PreferenceShareClass3 2017-01-01 2017-12-31 09744346 uk-core:ShareCapitalPreferenceShares 2017-12-31 09744346 uk-core:ShareCapitalPreferenceShares 2016-12-31 iso4217:EUR xbrli:shares

Registered Number 09744346

MEDIPOINTER LTD

Dormant Accounts

31 December 2017

MEDIPOINTER LTD Registered Number 09744346

Balance Sheet as at 31 December 2017

2017 2016
€ €
Current assets
Cash at bank and in hand
100
100
Net assets
100
100
Issued share capital
100 ord Shares of € 1 each 100 100
Total Shareholder funds
100
100

STATEMENTS

  1. For the year ending 31 December 2017 the company was entitled to exemption under section 480 of the Companies Act 2006 relating to dormant companies.
  2. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
  3. The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
  4. These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 6 September 2018

And signed on their behalf by:
Rene de la Porte, Director